The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia

被引:0
|
作者
Marion A. Becker
M. Scott Young
Ezra Ochshorn
Ronald J. Diamond
机构
[1] University of South Florida,Department of Mental Health Law & Policy—MHC 2735, Louis de la Parte Florida Mental Health Institute
[2] University of South Florida,Department of Mental Health Law & Policy—MHC 2603, Louis de la Parte Florida Mental Health Institute
[3] University of South Florida,Department of Mental Health Law & Policy—MHC 2625G, Louis de la Parte Florida Mental Health Institute
[4] University of Wisconsin-Madison,Department of Psychiatry
来源
Administration and Policy in Mental Health and Mental Health Services Research | 2007年 / 34卷
关键词
Antipsychotic medication; Adherence; Medicaid; Cost-effectiveness;
D O I
暂无
中图分类号
学科分类号
摘要
While some studies show a significant advantage in adherence rates with use of atypical versus typical antipsychotic medication, others show no advantage or mixed results (Jones et al. (2006). Archives of General Psychiatry, 63, 1079–1087; Rosenheck, (2006). Archives of General Psychiatry, 63, 1074–1076). This study examined treatment outcomes and costs associated with adherence rates by antipsychotic medication class for adult Medicaid beneficiaries in Florida diagnosed with schizophrenia. Outcomes examined include arrests, involuntary commitments, and physical and behavioral healthcare costs. Study findings demonstrate that medication adherence for persons with schizophrenia may be as important to treatment costs and benefits as the class of medication used.
引用
收藏
页码:307 / 314
页数:7
相关论文
共 50 条
  • [11] EMPIRICAL VALIDITY OF THE QUALITY MEASURE 'ADHERENCE TO ANTIPSYCHOTIC MEDICATIONS FOR INDIVIDUALS WITH SCHIZOPHRENIA' AMONG MEDICAID BENEFICIARIES
    Jadhav, S.
    Nasruddin, S.
    Imeri, H.
    Ramachandran, S.
    Bhattacharya, K.
    Pittman, E.
    VALUE IN HEALTH, 2023, 26 (06) : S196 - S196
  • [12] ASSESSMENT OF PATIENT OUT-OF-POCKET COSTS FOR ANTIPSYCHOTIC TREATMENTS AMONG MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA
    Lin, D.
    Pilon, D.
    Benson, C.
    Morrison, L.
    Shah, A.
    Lafeuille, M. H.
    Lefebvre, P.
    VALUE IN HEALTH, 2021, 24 : S129 - S129
  • [13] ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA PATIENTS
    Pregelj, Peter
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2009, 78 (01): : 33 - 36
  • [14] Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia
    Cai, Chao
    Kozma, Chris
    Patel, Charmi
    Benson, Carmela
    Yunusa, Ismaeel
    Zhao, Pujing
    Reeder, Gene
    Narasimhan, Meera
    Bank, Robert L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (06): : 549 - 559
  • [15] Antipsychotic Medication Adherence and Diabetes-Related Hospitalizations Among Medicaid Recipients With Diabetes and Schizophrenia
    Egglefield, Katie
    Cogan, Lindsay
    Leckman-Westin, Emily
    Finnerty, Molly
    PSYCHIATRIC SERVICES, 2020, 71 (03) : 236 - 242
  • [16] Continuity of Antipsychotic Medication Management for Medicaid Patients With Schizophrenia
    Farley, Joel F.
    Wang, Chi-Chuan
    Hansen, Richard A.
    Voils, Corrine I.
    Maciejewski, Matthew L.
    PSYCHIATRIC SERVICES, 2011, 62 (07) : 747 - 752
  • [17] Adherence to antipsychotic medication in indigenous patients with schizophrenia
    Caqueo-Urizar, Alejandra
    Urzua M, Alfonso
    Miranda-Castillo, Claudia
    Irarrazaval, Matias
    SALUD MENTAL, 2016, 39 (06) : 303 - 310
  • [18] Antipsychotic Switching and Heterogeneity in Treatment Costs for Persons with Schizophrenia in the Maryland Medicaid Program
    Salkever, David
    Abrams, Michael
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2011, 14 : S29 - S29
  • [19] Medication Continuity Among Medicaid Beneficiaries With Schizophrenia and Bipolar Disorder
    Brown, Jonathan D.
    Barrett, Allison
    Caffery, Emily
    Hourihan, Kerianne
    Ireys, Henry T.
    PSYCHIATRIC SERVICES, 2013, 64 (09) : 878 - 885
  • [20] ANTIPSYCHOTIC MEDICATION IN THE TREATMENT OF SCHIZOPHRENIA
    KANE, JM
    ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 1995, 32 (01): : 30 - 37